作者:Mark E. Sanders、Matthew M. Ames
DOI:10.1016/s0040-4039(00)95006-8
日期:1985.1
The clinically effective anticancer agent hexamethylmelamine undergoes an unusual acylhydroperoxide oxidative transformation to give the novel product 2,4-bis(dimethylamino)-6-[(dimethylamino)oxy]-1,3,5-triazine.
临床上有效的抗癌药六甲基三聚氰胺经历了异常的酰基氢过氧化物氧化转化,从而生成了新产品2,4-双(二甲基氨基)-6-[(二甲基氨基)氧基] -1,3,5-三嗪。